Alexander Zabala
Overview
Explore the profile of Alexander Zabala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zabala A, Gottsater A, Lind M, Eliasson B, Bertilsson R, Ekelund J, et al.
Diab Vasc Dis Res
. 2023 Jun;
20(3):14791641231176767.
PMID: 37340709
Aims: To investigate the association between glycemic control and outcome in people with type 2 diabetes (T2D) after carotid intervention due to carotid stenosis. Methods: Observational nationwide population-based cohort study...
2.
Vercalsteren E, Karampatsi D, Dekens D, Letsiou A, Zabala A, Romanitan M, et al.
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36835405
Type 2 diabetes (T2D) impairs post-stroke recovery, and the underlying mechanisms are unknown. Insulin resistance (IR), a T2D hallmark that is also closely linked to aging, has been associated with...
3.
Karampatsi D, Zabala A, Wilhelmsson U, Dekens D, Vercalsteren E, Larsson M, et al.
Cardiovasc Diabetol
. 2021 Dec;
20(1):240.
PMID: 34937562
Background: Post-stroke functional recovery is severely impaired by type 2 diabetes (T2D). This is an important clinical problem since T2D is one of the most common diseases. Because weight loss-based...
4.
Zabala A, Darsalia V, Lind M, Svensson A, Franzen S, Eliasson B, et al.
Cardiovasc Diabetol
. 2021 Oct;
20(1):202.
PMID: 34615525
Background And Aims: Insulin resistance contributes to the development of type 2 diabetes (T2D) and is also a cardiovascular risk factor. The aim of this study was to investigate the...
5.
Augestad I, Dekens D, Karampatsi D, Elabi O, Zabala A, Pintana H, et al.
Br J Pharmacol
. 2021 May;
179(4):677-694.
PMID: 33973246
Background And Purpose: Glucagon-like peptide-1 (GLP-1) receptor activation decreases stroke risk in people with Type 2 diabetes (T2D), while animal studies have shown the efficacy of this strategy to counteract...
6.
Zabala A, Gottsater A, Lind M, Svensson A, Eliasson B, Bertilsson R, et al.
Cardiovasc Diabetol
. 2021 Apr;
20(1):85.
PMID: 33894785
Objectives: To investigate early and long-term outcomes after treatment of carotid artery stenosis in patients with type 2 diabetes (T2D) compared to patients without T2D. Design/method: This observational nationwide population-based...
7.
Zabala A, Darsalia V, Holzmann M, Franzen S, Svensson A, Eliasson B, et al.
Diabetes Obes Metab
. 2019 Oct;
22(2):182-190.
PMID: 31576643
Aims: To compare stroke incidence in people with type 2 diabetes (T2D) with that in a matched control group, and to investigate whether glucose exposure in people with T2D can...